Publications by authors named "Igor Matushansky"

Claim this Profile
U
UV-induced multifocal cutaneous high-grade leiomyosarcoma.
Jacqueline Kloos, Matthew Ehrlich, Bret Taback, Igor Matushansky

BMJ Case Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Characterization of a Novel Non-Lytic Cancer Immunotherapy Using a Recombinant Arenavirus Vector Platform.
Henning Lauterbach, Sarah Schmidt, Kia Katchar, Xiaoping Qing, Corinne Iacobucci, Igor Matushansky

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-attenuated lymphocytic choriomeningitis virus-based vaccines for active immunotherapy of HPV16-positive cancer.
Sarah Schmidt, Weldy V Bonilla, Andrea Reiter, Felix Stemeseder, Theresa Kleissner, Igor Matushansky

Oncoimmunology· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy use in elderly patients with soft tissue sarcoma: a population-based study.
Igor Matushansky, Filemon Dela Cruz, Beverly J Insel, Dawn L Hershman, Alfred I Neugut

Cancer Invest· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hiwi mediated tumorigenesis is associated with DNA hypermethylation.
Sara Siddiqi, Melissa Terry, Igor Matushansky

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid tumor differentiation therapy - is it possible?
Filemon Dela Cruz, Igor Matushansky

Oncotarget· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.
Filemon Dela Cruz, Melissa Terry, Igor Matushansky

Differentiation· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARγ agonists enhance ET-743-induced adipogenic differentiation in a transgenic mouse model of myxoid round cell liposarcoma.
Elizabeth Charytonowicz, Melissa Terry, Katherine Coakley, Leonid Telis, Fabrizio Remotti, Igor Matushansky

J Clin Invest· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation.
Elizabeth Charytonowicz, Igor Matushansky, Josep Domingo Doménech, Mireia Castillo-Martín, Marc Ladanyi

Clin Transl Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piwis and piwi-interacting RNAs in the epigenetics of cancer.
Sara Siddiqi, Igor Matushansky

J Cell Biochem· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
Filemon Dela Cruz, Igor Matushansky

Discov Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis.
Elizabeth Charytonowicz, Igor Matushansky, Mireia Castillo-Martin, Todd Hricik, Carlos Cordon-Cardo

Clin Transl Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.
Igor Matushansky, Robert N Taub

Nat Rev Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromatin structure predicts epigenetic therapy responsiveness in sarcoma.
Joslyn Mills, Todd Hricik, Sara Siddiqi, Igor Matushansky

Mol Cancer Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic remodeling of chromatin architecture: exploring tumor differentiation therapies in mesenchymal stem cells and sarcomas.
Sara Siddiqi, Joslyn Mills, Igor Matushansky

Curr Stem Cell Res Ther· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and comparison of the properties of sarcoma cell lines in vitro and in vivo.
Joslyn Mills, Tulio Matos, Elizabeth Charytonowicz, Todd Hricik, Mireia Castillo-Martin, Igor Matushansky

Hum Cell· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21st Century.
Igor Matushansky, Elizabeth Charytonowicz, Joslyn Mills, Sara Siddiqi, Todd Hricik

Expert Rev Anticancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?
Elizabeth Charytonowicz, Carlos Cordon-Cardo, Igor Matushansky, Mel Ziman

Cancer Lett· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.
Igor Matushansky, Eva Hernando, Nicholas D Socci, Tulio Matos, Joslyn Mills

Am J Pathol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A context dependent role for Wnt signaling in tumorigenesis and stem cells.
Igor Matushansky, Robert G Maki, Carlos Cordon-Cardo

Cell Cycle· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway.
Igor Matushansky, Eva Hernando, Nicholas D Socci, Joslyn E Mills, Tulio A Matos

J Clin Invest· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
Eva Hernando, Elizabeth Charytonowicz, Maria E Dudas, Silvia Menendez, Igor Matushansky

Nat Med· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of sarcomagenesis.
Igor Matushansky, Robert G Maki

Hematol Oncol Clin North Am· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PU.1 and pRB interact and cooperate to repress GATA-1 and block erythroid differentiation.
Natasha Rekhtman, Kevin S Choe, Igor Matushansky, Stuart Murray, Tomas Stopka

Mol Cell Biol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of tumorigenicity and the block to differentiation in erythroleukemia cells by GATA-1.
Kevin S Choe, Farshid Radparvar, Igor Matushansky, Natasha Rekhtman, Xing Han

Cancer Res· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis